Reference data : LOINC code

Filter


Clear filter

Results
108,248 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType <span class='defaultText'>DefinitionDescription</span> dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
1011-6 E super little w Ab PrThr Ser/Plas^Donor Pt Ord &nbsp; &nbsp; ACTIVE E sup(w) Ab [Presence] in Serum or Plasma from Donor &nbsp; NAM DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; BLDBK &nbsp; 1011-6 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 E sup(w) Ab SerPl Donr Ql &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Donr; E sup(w); Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.63 1 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. Added 'super' to indicate the 'w' is a superscript to the E antigen. 0
10110-5 ST wave displacement.end.lead II Elpot Heart Pt Qn EKG &nbsp; ACTIVE ST wave end displacement in lead II &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mV &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; EKG.MEAS &nbsp; 10110-5 &nbsp; EKG &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 ST wave ED L-II &nbsp; &nbsp; &nbsp; Y &nbsp; 2; Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Eklund; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST wave ED L-II; Voltage 2.48 1.0i &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mV &nbsp; &nbsp; &nbsp; 0
101100-6 K little u Ag PrThr RBC Pt Ord &nbsp; &nbsp; ACTIVE Ku Ag [Presence] on Red Blood Cells &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; BLDBK &nbsp; 101100-6 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Ku Ag RBC Ql &nbsp; &nbsp; &nbsp; N &nbsp; Antigen; Antigens; BLOOD BANK; Erythrocytes; Ku; Ku Ag; MNSs Blood Group System; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen 2.75 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
101101-4 K little x Ab PrThr Ser/Plas Pt Ord &nbsp; &nbsp; ACTIVE Kx Ab [Presence] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; BLDBK &nbsp; 101101-4 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Kx Ab SerPl Ql &nbsp; &nbsp; &nbsp; N &nbsp; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Kell Blood Group System; Kx; Kx Ab; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.75 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
101102-2 K little x Ag PrThr RBC Pt Ord &nbsp; &nbsp; ACTIVE Kx Ag [Presence] on Red Blood Cells &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; BLDBK &nbsp; 101102-2 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Kx Ag RBC Ql &nbsp; &nbsp; &nbsp; N &nbsp; Antigen; Antigens; BLOOD BANK; Erythrocytes; Kx; Kx Ag; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen 2.75 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
101103-0 C super G Ab PrThr Ser/Plas Pt Ord &nbsp; &nbsp; ACTIVE C^G Ab [Presence] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; BLDBK &nbsp; 101103-0 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 C^G Ab SerPl Ql &nbsp; &nbsp; &nbsp; N &nbsp; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; C^G; C^G Ab; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.75 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
101104-8 Minimum Data Set (MDS) - version 3.0 - Resident Assessment Instrument (RAI) version 1.18.11 - ^Patient RptPeriod - CMS Assessment &nbsp; ACTIVE Minimum Data Set (MDS) - version 3.0 - Resident Assessment Instrument (RAI) version 1.18.11 during assessment period [CMS Assessment] &nbsp; PANEL DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.SURVEY.CMS &nbsp; 101104-8 &nbsp; CMS Assessment &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; Centers for Medicare and Medicaid Assessment; MDS; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey 2.77 2.74 &nbsp; Convenience group &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Release 2.77: TIME_ASPCT: Decision by CMS to update the Timing to RptPeriod from Pt for all CMS Assessments; 0
101105-5 MDS v3.0 - RAI v1.18.11 - Nursing home comprehensive (NC) item set - ^Patient RptPeriod - CMS Assessment &nbsp; ACTIVE MDS v3.0 - RAI v1.18.11 - Nursing home comprehensive (NC) item set during assessment period [CMS Assessment] &nbsp; PANEL DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.SURVEY.CMS &nbsp; 101105-5 &nbsp; CMS Assessment &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey 2.77 2.74 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Release 2.77: TIME_ASPCT: Decision by CMS to update the Timing to RptPeriod from Pt for all CMS Assessments; 0
101106-3 MDS v3.0 - RAI v1.18.11 - Nursing home quarterly (NQ) item set - ^Patient RptPeriod - CMS Assessment &nbsp; ACTIVE MDS v3.0 - RAI v1.18.11 - Nursing home quarterly (NQ) item set during assessment period [CMS Assessment] &nbsp; PANEL DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.SURVEY.CMS &nbsp; 101106-3 &nbsp; CMS Assessment &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey 2.77 2.75 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Release 2.77: TIME_ASPCT: Decision by CMS to update the Timing to RptPeriod from Pt for all CMS Assessments; 0
101107-1 MDS v3.0 - RAI v1.18.11 - Nursing home discharge (ND) item set - ^Patient RptPeriod - CMS Assessment &nbsp; ACTIVE MDS v3.0 - RAI v1.18.11 - Nursing home discharge (ND) item set during assessment period [CMS Assessment] &nbsp; MAJ DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.SURVEY.CMS &nbsp; 101107-1 &nbsp; CMS Assessment &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey 2.77 2.75 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Release 2.77: TIME_ASPCT: Decision by CMS to update the Timing to RptPeriod from Pt for all CMS Assessments; 0
101108-9 MDS v3.0 - RAI v1.18.11 - Nursing home & Swing bed tracking (NT & ST) item set - ^Patient RptPeriod - CMS Assessment &nbsp; ACTIVE MDS v3.0 - RAI v1.18.11 - Nursing home and Swing bed tracking (NT and ST) item set [CMS Assessment] &nbsp; MAJ DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.SURVEY.CMS &nbsp; 101108-9 &nbsp; CMS Assessment &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey 2.77 2.75 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Release 2.77: TIME_ASPCT: Decision by CMS to update the Timing to RptPeriod from Pt for all CMS Assessments; 0
101109-7 MDS v3.0 - RAI v1.18.11 - Nursing home part A PPS discharge (NPE) item set - ^Patient RptPeriod - CMS Assessment &nbsp; ACTIVE MDS v3.0 - RAI v1.18.11 - Nursing home part A PPS discharge (NPE) item set during assessment period [CMS Assessment] &nbsp; MAJ DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.SURVEY.CMS &nbsp; 101109-7 &nbsp; CMS Assessment &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey 2.77 2.75 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Release 2.77: TIME_ASPCT: Decision by CMS to update the Timing to RptPeriod from Pt for all CMS Assessments; 0
10111-3 ST wave displacement.end.lead III Elpot Heart Pt Qn EKG &nbsp; ACTIVE ST wave end displacement in lead III &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mV &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; EKG.MEAS &nbsp; 10111-3 &nbsp; EKG &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 ST wave ED L-III &nbsp; &nbsp; &nbsp; Y &nbsp; 3; Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Eklund; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST wave ED L-III; Voltage 2.48 1.0i &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mV &nbsp; &nbsp; &nbsp; 0
101110-5 MDS v3.0 - RAI v1.18.11 - Nursing home PPS (NP) item set - ^Patient RptPeriod - CMS Assessment &nbsp; ACTIVE MDS v3.0 - RAI v1.18.11 - Nursing home PPS (NP) item set during assessment period [CMS Assessment] &nbsp; MAJ DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.SURVEY.CMS &nbsp; 101110-5 &nbsp; CMS Assessment &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey 2.77 2.75 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Release 2.77: TIME_ASPCT: Decision by CMS to update the Timing to RptPeriod from Pt for all CMS Assessments; 0
101111-3 MDS v3.0 - RAI v1.18.11 - Interim Payment Assessment (IPA) item set - ^Patient RptPeriod - CMS Assessment &nbsp; ACTIVE MDS v3.0 - RAI v1.18.11 - Interim Payment Assessment (IPA) item set during assessment period [CMS Assessment] &nbsp; PANEL DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.SURVEY.CMS &nbsp; 101111-3 &nbsp; CMS Assessment &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey 2.81 2.75 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Release 2.77: TIME_ASPCT: Decision by CMS to update the Timing to RptPeriod from Pt for all CMS Assessments; 0
101112-1 MDS v3.0 - RAI v1.18.11 - Swing bed PPS (SP) item set - ^Patient RptPeriod - CMS Assessment &nbsp; ACTIVE MDS v3.0 - RAI v1.18.11 - Swing bed PPS (SP) item set during assessment period [CMS Assessment] &nbsp; PANEL DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.SURVEY.CMS &nbsp; 101112-1 &nbsp; CMS Assessment &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; species; spp; Survey 2.77 2.75 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Release 2.77: TIME_ASPCT: Decision by CMS to update the Timing to RptPeriod from Pt for all CMS Assessments; 0
101113-9 MDS v3.0 - RAI v1.18.11 - Swing bed discharge (SD) item set - ^Patient RptPeriod - CMS Assessment &nbsp; ACTIVE MDS v3.0 - RAI v1.18.11 - Swing bed discharge (SD) item set during assessment period [CMS Assessment] &nbsp; MAJ DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.SURVEY.CMS &nbsp; 101113-9 &nbsp; CMS Assessment &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey 2.77 2.75 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Release 2.77: TIME_ASPCT: Decision by CMS to update the Timing to RptPeriod from Pt for all CMS Assessments; 0
101114-7 National Council of State Boards of Nursing ID ID Provider Pt Nom &nbsp; &nbsp; ACTIVE NCSBN ID &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ADMIN.ID &nbsp; 101114-7 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 NCSBN ID &nbsp; &nbsp; &nbsp; N &nbsp; ADMIN; Ident; Identifier; Intradermal; NCSBN ID; Nominal; Point in time; Random 2.74 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
101115-4 Leukotriene E4/Creatinine MRto Urine 24H Qn &nbsp; &nbsp; ACTIVE Leukotriene E4/Creatinine [Mass Ratio] in 24 hour Urine &nbsp; MIN DefinitionDescription &nbsp; &nbsp; pg/mg creatinine &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 101115-4 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 LTE4/Creat 24h Ur &nbsp; &nbsp; &nbsp; N &nbsp; 1 day; 24 hours; 24HR; 7,9,11,14-Eicosatetraenoic acid, 6-((2-amino-2-carboxyethyl)thio)-5-hydroxy-, (5S-(5R*,6S*(S*),7E,9E,11Z,14Z)); Chemistry; CR; Crea; Creat; LTE4; Mass concentration ratio; Mass ratio; MCRto; QNT; Quan; Quant; Quantitative; UA; UCr; UR; Urn 2.75 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; pg/mg{creat} &nbsp; &nbsp; &nbsp; 0
101116-2 Thrombospondin type I domain-containing 7A Ag PrThr Tiss Pt Ord IF &nbsp; ACTIVE THSD7A Ag [Presence] in Tissue by Immunofluorescence &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PATH &nbsp; 101116-2 &nbsp; IF &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 THSD7A Ag Tiss Ql IF &nbsp; &nbsp; &nbsp; N &nbsp; ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; DFA; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Neuro; Neurology; Ordinal; Pathology; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Thrombospondin Type-1 Domain-Containing 7A; THSD7A; THSD7A Ag; Time Resolved Fluorescence; Tissue; Tissue, unspecified; TRF 2.75 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
101117-0 Sezary syndrome monitoring Find Bld Pt Doc Flow cytometry &nbsp; ACTIVE Sezary syndrome monitoring in Blood Document by Flow cytometry (FC) &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CELLMARK &nbsp; 101117-0 &nbsp; Flow cytometry &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Sezary syndrome monitoring Bld Doc FC &nbsp; &nbsp; &nbsp; N &nbsp; Blood; CELL MARKERS; Document; Dynamic; FC; Finding; Findings; Point in time; Random; WB; Whole blood 2.75 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
101118-8 Sezary syndrome diagnosis Find Bld Pt Doc Flow cytometry &nbsp; ACTIVE Sezary syndrome diagnosis in Blood Document by Flow cytometry (FC) &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CELLMARK &nbsp; 101118-8 &nbsp; Flow cytometry &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Bld Doc FC &nbsp; &nbsp; &nbsp; N &nbsp; Blood; CELL MARKERS; Document; Dx; Dynamic; FC; Finding; Findings; Point in time; Random; WB; Whole blood 2.75 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
101119-6 Leukemia and lymphoma immunophenotyping Find XXX Pt Doc Flow cytometry &nbsp; ACTIVE Leukemia and lymphoma immunophenotyping in Specimen Document by Flow cytometry (FC) &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CELLMARK &nbsp; 101119-6 &nbsp; Flow cytometry &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Leuk and lymphma immnphntypng Spec &nbsp; &nbsp; &nbsp; N &nbsp; CELL MARKERS; Document; Dynamic; FC; Finding; Findings; Leukemia and lymphoma immnphntypng; Misc; Miscellaneous; Other; Point in time; Random; Spec; To be specified in another part of the message; Unspecified 2.75 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
10112-1 ST wave displacement.end.lead V1 Elpot Heart Pt Qn EKG &nbsp; ACTIVE ST wave end displacement in lead V1 &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mV &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; EKG.MEAS &nbsp; 10112-1 &nbsp; EKG &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 ST wave ED L-V1 &nbsp; &nbsp; &nbsp; Y &nbsp; Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Eklund; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST wave ED L-V1; Voltage 2.48 1.0i &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mV &nbsp; &nbsp; &nbsp; 0
101120-4 Candida glabrata+krusei DNA PrThr Bld Pt Ord Probe.amp.tar &nbsp; ACTIVE Candida glabrata+krusei DNA [Presence] in Blood by NAA with probe detection &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; MICRO &nbsp; 101120-4 &nbsp; Probe.amp.tar &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Candida glabrata+krusei DNA Bld Ql NAA probe det &nbsp; &nbsp; &nbsp; N &nbsp; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; C glabrata; C glabrata+krusei; C glabrata+krusei DNA; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Torulopsis glabrata; Transcription mediated amplification; WB; Whole blood 2.75 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
108,248 results found